Idexx laboratories announces third quarter results

Westbrook, maine, nov. 2, 2021 /prnewswire/ --  achieves third quarter revenue growth of 12% as reported and 10% on an organic basis compared to high prior year growth levels results driven by continued strong cag business momentum, reflected in cag diagnostics recurring revenue growth of 13% reported and 11.5% organic and record q3 global premium instrument placements delivers eps of $2.03, representing 20% growth as reported and 12% on a comparable basis updates 2021 guidance to higher end of previous guidance ranges, reflecting revenue growth outlook of 17.5% - 18% as reported and 15.5% - 16% organic, and eps growth of 24% - 25% as reported and 26% - 27% on a comparable basis idexx laboratories, inc. (nasdaq: idxx), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced third quarter results, as well as an update on u.s. companion animal diagnostics trends. third quarter results the company reports revenues of $810 million for the third quarter of 2021, an increase of 12% as reported and 10% organically.
IDXX Ratings Summary
IDXX Quant Ranking